Skip to main content
Figure 2 | Radiation Oncology

Figure 2

From: BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

Figure 2

Pseudo-coloured images of cross-sections from tumors excised 24 h after end of treatment with BAY-87-2243 or carrier for 3, 5 or 7 days. Green: hypoxia, pimonidazole; blue: perfusion, Hoechst 33342; red: vascular endothelium, CD31; grey: necrotic areas. Scale bar: 500 μm.

Back to article page